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Abstract
Objective: To estimate individual and household economic impact of cardiovascular disease (CVD) in selected low- and
middle-income countries (LMIC).
Background: Empirical evidence on the microeconomic consequences of CVD in LMIC is scarce.
Methods and Findings: We surveyed 1,657 recently hospitalized CVD patients (66% male; mean age 55.8 years) from
Argentina, China, India, and Tanzania to evaluate the microeconomic and functional/productivity impact of CVD
hospitalization. Respondents were stratified into three income groups. Median out-of-pocket expenditures for CVD
treatment over 15 month follow-up ranged from 354 international dollars (2007 INT$, Tanzania, low-income) to INT$2,917
(India, high-income). Catastrophic health spending (CHS) was present in.50% of respondents in China, India, and Tanzania.
Distress financing (DF) and lost income were more common in low-income respondents. After adjustment, lack of health
insurance was associated with CHS in Argentina (OR 4.73 [2.56, 8.76], India (OR 3.93 [2.23, 6.90], and Tanzania (OR 3.68 [1.86,
7.26] with a marginal association in China (OR 2.05 [0.82, 5.11]). These economic effects were accompanied by substantial
decreases in individual functional health and productivity.
Conclusions: Individuals in selected LMIC bear significant financial burdens following CVD hospitalization, yet with
substantial variation across and within countries. Lack of insurance may drive much of the financial stress of CVD in LMIC
patients and their families.
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Introduction
Cardiovascular disease (CVD) is the leading cause of mortality
and among the leading causes of morbidity worldwide [1]. On
average, CVD affects patients in low- and middle-income countries
(LMIC) ten to fifteen years earlier than high-income country
patients, reducing LMIC workforce capacity and potential
economic growth [2]. The number of potentially productive years
of life lost (PPYLL) due to CVD between ages 35–64 was estimated
to be 9.2 million (3,572 per 100,000) in India and 6.7 million (1,595
per 100,000) in China in 2000. These estimates are projected to rise
to 17.9 million PPYLL in India (3,707 PPYLL per 100,000) and
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10.5 million PPYLL in China (1,863 per 100,000), by 2030 [2]. On
a national scale, Tanzania, India and China are projected to lose 2.5
billion, 237 billion, and 558 billion 1998 international dollars in
gross domestic product (GDP), respectively, between 2005–2015
due to CVD, diabetes, and stroke [3]. To the best of our knowledge,
there are no similar estimates since 2000.
Beyond these macroeconomic projections, the 2000 World
Health Report used fairness in financing—defined as the ratio of a
household’s total health spending to its capacity to pay—as a key
indicator of health system performance (4). In this context, Xu and
colleagues estimated in 2007 that 150 million people suffer from
financial catastrophe (defined as annual health spending $40%
non-food income) due to out-of pocket spending on health care.
More than 90% of these people live in low-income countries
[4]. Despite the high prevalence of CVD and out-of-pocket
healthcare financing in LMIC, there are limited data evaluating
the association between acute CVD events and their economic
impact.
We conducted a standardized survey in four LMICs—Argentina,
China, India, and Tanzania—in order to quantify the effect of
hospitalization for a CVD event on (a) health care expenditures, (b)
how people financed health expenditures (c) impoverishment, and
(d) changes in functional capacity and productivity. We hypothe-
sized that a CVD event in a family member would produce a higher
effect on family financial stress in low income families and families
without health insurance.
Methods
Ethics Statement
The study was approved by a local ethics board for each par-
ticipating site. Specifically, approval was provided by ethics boards
located at the following institutions: Sree Chitra Tirunal Institute
for Medical Sciences and Technology, National Institute of
Medical Research, Muhimbili National Hospital, Capital Medical
University affiliated Beijing Anzhen Hospital & Beijing Institute of
Heart, Lung and Blood Vessel Diseases, and Hospital Italiano de
Buenos Aires. Written informed consent was obtained from each
participant in his or her primary language.
Recruitment
We performed a cross-sectional survey of recently hospitalized
CVD patients in Argentina (Buenos Aires, La Plata, Mar del Plata),
China (Beijing, Henan Zhoukou City), India (Trivandrum), and
Tanzania (Dar es Salaam, Mwanza, Zanzibar). Each country chose
three to seven hospitals, including a mix of public and private,
urban and rural, hospitals with and without advanced [interven-
tional] treatment facilities to cover a range of hospitalized parti-
cipants. Hospitalized CVD patients were sampled using a stratified,
random-sampling process based on age (,55 years old and $55
years old). All decisions related to in-hospital and follow-up medical
care were decided by the participant and his/her providing
physician. Surveys were developed by experts from the Initiative
for Cardiovascular Health Research in Developing Countries to
evaluate the individual- and household-level economic impact
of hospitalization for a CVD-related event. Questions related to
functionality were from adapted from the Short-Form-36.
Standardized surveys (Appendix S1) were translated from
English into local languages and culturally adapted by each
country site. A pilot study was performed at each site in order to
detect implementation difficulties. Surveys were conducted three
to fifteen months following hospital discharge. In order to evaluate
the economic diversity among the study participants, participants
were assigned to one of three income groups based upon the
discharge hospital, payment scheme within each hospital, and/or
participants’ income and/or expenditures. The poorest group re-
presented the poorest 40% (‘‘low’’), the middle group represented
the middle 40% (‘‘middle’’), and the wealthiest group represented
the top 20% (‘‘high’’) of the national population income distribution.
Inclusion/Exclusion Criteria
We included participants aged 25–70 years who had been
hospitalized for one or more of the following admission diagnoses:
acute coronary syndrome (ACS, including unstable angina or
myocardial infarction), stroke, acute heart failure, or peripheral
vascular intervention (including amputation). First-ever or repeat
CVD events were included. Exclusion criteria were any of the
following: active malignancy, end-stage renal disease requiring
dialysis, solid-organ or hematopoietic transplant, human immu-
nodeficiency virus infection, or severe mental illness.
Survey data were collected in the outpatient clinic or in the
household in 2008–2009 by trained personnel to evaluate: 1)
demography, 2) medical history, 3) individual and household eco-
nomic information, 4) expenditures on CVD treatment associated
with antecedent CVD event (including indirect costs), and 5) effect
of a CVD event on health and productivity. Estimated costs were
based upon the total inpatient and follow-up costs up to 15 months
and were confirmed by chart review.
Definitions
A household’s health spending was considered catastrophic if
annual out-of-pocket health expenditures were $40% of total,
non-food household expenditures, since such spending is likely to
result in impoverishment [5,6]. Distress financing was defined as
financial activities, such as borrowing money from relatives/
friends, taking loans from banks/other lenders, or selling assets
(property, e.g.), that were directly related to the patient’s most
recent hospitalization.
Statistical Analyses
In order to assess the economic impact of CVD at different
income levels, each national group was stratified into income
groups. Continuous variables are reported as means 6 standard
deviation or, if skewed in distribution, as median with interquartile
range. Categorical variables are reported as proportions (%).
Continuous variables were compared using t tests and one-way
ANOVA, and categorical variables were compared using the chi-
square test. We used univariate and multivariate logistic regression
to assess the determinants of catastrophic health spending and
distress financing. The multivariate models were constructed using
those variables that were significant (p,0.1) in the univariate
models and included a dichotomy variable to reflect the type of
event, that is 1 for acute coronary syndrome and 0 for stroke.
Income and expenditures across all countries were compared using
the purchasing power parity conversion to 2007 international
dollars (INT$) (7).
Results
Demography, Baseline Economic Information, Medical
History, and Presentation
Mean participant age ranged from 53 years (Tanzania) to 59
years (China), and the majority of participants were male (Table 1).
Median number of years of education completed ranged from
seven in Tanzania to ten in India. Median overall monthly
individual incomes varied considerably across countries and were
lowest in India (INT$259/month) and highest in Argentina
(INT$975/month). Significant intra-country variability across
Microeconomic Impact of Cardiovascular Disease
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20821
income groups was present. A similar pattern was seen for monthly
household income. Baseline unemployment ranged from 6% to
24% and was most common in the low-income group. Overall,
lack of health insurance was common. Hypertension and tobacco
use were among the most common CVD risk factors, and ACS
and stroke were the most common admission diagnoses. Median
length of stay ranged from 5 to 12 days. Median (interquartile
range) time to survey completion following hospital discharge
ranged from 174 (83, 264) days in Tanzania to 369 (306, 404) days
in China (Table 1).
Table 1. Baseline characteristics of survey participants.
Argentina
N=367
China
N=290
India
N=500
Tanzania
N=498
DEMOGRAPHICS
Mean age, years (SD) 56.6 (8.5) 59.3 (8.1) 56.1 (8.9) 52.9 (11.0)
Male, % 74.1 62.4 79.0 50.2
Married, % 59 94.5 90.0 72.4
Rural, % (National rural prevalence) 3.0 (8) 33.8 (57) 55.0 (70) 42.4 (74)
Median education level, years (IQR) 9 (6, 12) 9 (6, 11) 10 (8,12) 7 (3.5, 10.5)
Median time to survey completion, days (IQR) 251 (148, 354) 369 (306, 404) 240 (150, 330) 174 (83, 264)
Purchasing power parity conversion to INT$1{ 1.54 ARS 4.09 RMB 16.54 INR 521 TZS
INCOME/INSURANCE
Median baseline monthly individual income, INT$ (IQR) 975.3
(650, 1,300)
330.0
(198, 489)
258.5
(60, 544)
326.0
(0, 653)
Income stratum
Low (Lowest 40%) 650.2 73.3 136.1 97.7
Middle (Middle 40%) 1,300.4 220.2 181.4 191.9
High (Highest 20%) 2,600.8* 391.1* 302.4* 767.8*
Median baseline monthly household income, INT$ (IQR) 1,300.4
(813, 1,788)
611.1
(367, 978)
453.5
(259, 907)
768.0
(322, 1,215)
Income stratum
Low (Lowest 40%) 780.2 122.2 211.6 479.9
Middle (Middle 40%) 1755.5 366.7 302.4 767.8
High (Highest 20%) 3901.2* 855.5* 665.2* 1,919.4*
Dependents ,18 years old 36.8 0 46.1 71.7
Dependents .60 years old 42.9 25.0 52.3 48.9
Other individuals in household earning income 96.3 67.0 90.1 97.7
Unemployment, % 16.4 5.9 23.7 6.2
Income stratum
Low (Lowest 40%) 25.5 13.6 42.4 5.6
Middle (Middle 40%) 13.0 7.7 29.3 8.2
High (Highest 20%) 7.5 3.0* 18.4 2.1
Social/private health insurance, % 52.9 80.0 16.5 14.1
COMORBIDITIES
Hypertension, % 56.1 54.5 70.0 88.7
Current/prior tobacco use, % 57.6 10.7 41.0 15.2
Diabetes mellitus, % 19.2 16.6 43.4 16.1
COPD, % 2.7 1.4 3.2 4.4
HOSPITAL PRESENTATION
Acute coronary syndrome, % 66.8 45.9 68.0 1.8
Acute heart failure, % 12.5 0 0 37.1
Peripheral vascular disease, % 1.9 0 0 0.1
Stroke, % 20.0 54.1 32.0 60.4
Median days hospitalized, No. (IQR) 7 (1.5, 12.5) 12 (8, 19) 6 (4, 8) 5 (0, 7)
Mean, median (IQR), and proportions are shown. Differences across income groups are considered statistically significant if p,0.05 (*). Hospital presentation .100%
due to multiple causes of hospitalization in Argentina.
{Source: World Bank, available at http://web.worldbank.org/WBSITE/EXTERNAL/DATASTATISTICS/0,
contentMDK:20535285,menuPK:1192694,pagePK:64133150,piPK:64133175,theSitePK:239419,00.html, Accessed April 2010.
doi:10.1371/journal.pone.0020821.t001
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Expenditures, Microeconomic Effects, and Income Effects
of CVD Event
When CVD expenditure data were stratified by income groups
for each nation surveyed, median 15-month out-of-pocket CVD
health spending ranged from INT$374 (Tanzania, low-income
group) to INT$2,917 (India, high-income group), and median
annual household expenditures ranged from INT$1,701 (India,
low-income group) to INT$24,597 (Argentina, high-income
group)(Table 2). Out-of-pocket CVD expenditures were signifi-
cantly higher in high-income strata in India and Tanzania but
significantly lower in the high-income group in China. The pro-
portion of 15-month out-of-pocket CVD expenditures to annual
household expenditures ranged considerably from 4% (Argentina,
all income groups) to 55% (India, middle-income group).
Participants from all countries and all income strata reported a
decrease in individual incomes after a CVD event. Participants
from low-income strata were more likely to report a decrease in
individual income than those in the high-income stratum in
Argentina, China, and India, but not in Tanzania (Table 2).
Catastrophic health spending (CHS) occurred in all countries
and income strata, ranging from 5% (Argentina, high-income
stratum) to 92% (India and Tanzania, low-income strata). Distress
financing ranged from 1% (Argentina, high-income stratum) to
64% (India, low-income stratum) (Figure 1). Borrowing from
family, friends, and employers was the most common form of
distress financing, but the distribution of distress financing type
differed across countries (Appendix S2).
Private/social health insurance was significantly and inversely
associated with CHS in all countries by univariate analysis
(Tables 3 and 4) and remained significant after controlling for
other significant variables in Argentina (OR 4.73 [2.56, 8.76],
India (OR 3.93 [2.23, 6.90], and Tanzania (OR 3.68 [1.86, 7.26]
with a trend toward association in China (OR 2.05 [0.82, 5.11]).
(Table 3) CHS was also associated with the low-income group in
China, India, and Tanzania, an association that remained
statistically significant in India (OR 6.59 [2.23, 19.45]), after
adjustment for other significant variables. Distress financing was
predicted by low-income status in Argentina (OR 3.08 [1.12,
8.43]), China (OR 6.67 [1.69, 26.35]), and Tanzania (OR 3.25
[1.08, 9.75]), whereas income status in India was not associated
with distress financing (OR 1.30 [0.68, 2.49]). In India, health
insurance was the strongest predictor of avoiding distress financing
(OR 11.37 [5.18, 24.95]).
Argentina. In Argentina, 15-month out-of-pocket CVD ex-
penditures were similar across all income strata with a trend
toward increased costs in the high-income group. Private/social
health insurance coverage was moderate (52%) across all
respondents. Access to ambulatory and in-hospital care is fully
granted for all Argentineans, regardless of their insurance status or
hospital where they receive care. In this context, CHS was
relatively low across all groups but was significantly associated with
lack of private or social health insurance (OR 4.72 [2.56, 8.76]
Table 3). The proportion of distress financing was similar across all
income groups and was significantly associated low-income status
(OR 3.08 [1.12, 8.43]). Nevertheless, more than half of all par-
ticipants from Argentina reported that they had experienced a
decrease in individual and household income following their
CVD-related hospitalization (Table 2).
China. Overall out-of-pocket CVD expenditures were higher
among participants in the low-income stratum; the ratio of out-of-
pocket CVD spending to total household expenditures was also
higher. CHS was highest in the low-income stratum (71%) and
had a significant negative association with age,55 years (OR 0.47
[0.26, 0.85]) and significant positive association with rural status
(OR 2.69 [1.31, 5.53]) (Table 3). A similar distribution was seen
for distress financing, which was significantly associated with rural
status (OR 5.13 [1.53, 17.13] and low-income group (OR 6.67
[1.69, 26.35]). The subsequent proportion of participants who
experienced any decrease in income was highest in the low-income
group (53%), though the absolute decrease was highest in the high-
income group (Table 2).
India. India had the highest 15-month out-of-pocket CVD
expenditures among the comparator countries. Insurance cove-
rage was uncommon in Indian respondents (16%), and overall
CHS was common and regressive. CHS was associated with age
,55 years (OR 1.66 [1.06, 2.61]), lack of private/social health
insurance (OR 3.93 [2.23, 19.45]), and stroke (OR 0.60 [0.37,
0.97]) (Table 4). A similar pattern was seen for distress financing,
which was again higher than other comparator countries. Rural
status (OR 1.93 [1.27, 2.93]), less than secondary school education
(OR 2.27 [1.34, 3.86], absence of private/social health insurance
(OR 11.37 [5.18, 24.95]), and stroke (OR 0.32 [0.21, 0.51]) were
significantly associated with distress financing. The proportion of
participants who experienced any decrease in income was highest
in the low-income stratum (43%), but the absolute decrease was
also highest in the low-income group (Table 2).
United Republic of Tanzania. In Tanzania, increased 15-
month out-of-pocket CVD expenditures were associated with
the high-income respondents, as were annual household costs.
Insurance coverage was low throughout Tanzania (14%). As such,
CHS was high in all income groups and was associated with rural
status (OR 2.00 [1.07, 3.73]) and lack of private/social health
insurance (OR 3.68 [1.86, 7.26] Table 4). Distress financing was
uncommon, however, and ranged from 4% to 12% and was only
associated with low-income group (OR 3.25 [1.08, 9.75]).
Nevertheless, two-thirds of respondents reported a decrease in
income following their CVD-related hospitalization. The pro-
portion of respondents experiencing any decrease in income was
similar across income groups (Table 2).
Functional Capacity and Productivity
The health effects, functional effects, and household effects of
CVD-related hospitalization demonstrate the potential indirect
economic impact of CVD-related hospitalization (Table 5). Most
respondents experienced functional limitations in moderate and
vigorous activities with subsequent emotional distress following
their hospitalization. Individual decreases in work time and work
activities were common coping mechanisms, whereas families re-
sponded by a net increase (Argentina, China, India) or net decrease
(Tanzania) in work time to compensate for their family member’s
disability.
Argentina. Approximately 50% of participants across all
income strata reported a decrease in their health with nearly all
reporting a decrease in their ability to participate in moderate
(86%) or vigorous (88%) activities. The proportion of individuals
experiencing emotional problems following their CVD-related
hospitalization was also high (61%). Cost was the primary reason
for not taking one’s medications in 7–13% of respondents.
Most respondents reported a decrease in work time (73%) and
reported limiting their work activities (78%) following their CVD-
related hospitalization. The low-income stratum was more likely to
report feeling limited overall (87%), but this response was common
for the entire group (67%). Family members were more likely to
increase their work time (or start new work) rather than report a
decrease in their work time (or stop work)(Table 5).
China. The majority of respondents reported a decrease in
their self-rated health (62%), while half (51%) of participants were
less able to perform moderate physical activities and three-fourths
Microeconomic Impact of Cardiovascular Disease
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(76%) of participants were less able to perform vigorous physical
activities. Approximately one-fourth of the respondents did not
take their medications due to cost (Table 5).
Most respondents decreased their work time (81%) and limited
their work activities (87%) following their CVD-related hospital-
ization. The overall proportion of family members who increased
Figure 1. Proportion of survey respondents who experienced catastrophic health spending (out-of-pocket health spending .40%
non-food expenditures) and distress financing following CVD-related hospitalization, divided by income strata. Differences across
income strata were considered statistically significant (p,0.05) for China (CHS and DF), India (CHS), and Tanzania (CHS and DF).
doi:10.1371/journal.pone.0020821.g001
Table 3. Univariate and multivariate logistic regression models for catastrophic health spending and distress financing by for
Argentina and China (see Table 4 for India and Tanzania).
Catastrophic Health Spending Distress Financing
Univariate
analysis
p-
value
Multivariate
analysis
p-
value
Univariate
analysis
p-
value
Multivariate
analysis
p-
value
Argentina (n =367) OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI]
Age Group: ,55 vs. ./ = 55 (ref) 1.22 [0.69, 2.17] 0.50 Not in final model N/A 1.05 [0.68, 1.62] 0.82 Not in final model N/A
Place of Residence: urban (ref) vs. rural 1.91 [0.24, 15.22] 0.54 Not in final model N/A 0.41 [0.13, 1.30] 0.13 Not in final model N/A
Education level: below high school
vs. high school or above (ref)
1.01 [0.54, 1.90] 0.98 Not in final model N/A 0.70 [0.42, 1.17] 0.18 Not in final model N/A
Employment: Yes (ref) vs. No 1.62 [0.84, 3.10] 0.15 Not in final model N/A 3.47 [2.06, 5.82] ,0.001 3.45 [2.00, 5.94] ,0.001
Social/private insurance: Yes (ref) vs. No 4.07 [2.33, 7.11] ,0.001 4.73 [2.56, 8.76] ,0.001 1.31 [0.85, 2.04] 0.22 Not in final model N/A
Highest income group (ref) Reference Reference Reference Reference
Middle income group 2.91 [0.66, 12.83] 0.16 Not in final model N/A 2.74 [1.02, 7.36] 0.046 2.60 [0.95, 7.07] 0.06
Lowest income group 3.99 [0.91, 17.59] 0.07 Not in final model N/A 3.79 [1.41, 10.21] 0.01 3.08 [1.12, 8.43] 0.03
Presentation: ACS (ref) vs. stroke 2.25 [0.97, 5.20] 0.06 Not in final model N/A 0.82 [0.49, 1.37] 0.454 Not in final model N/A
China (n =290)
Age Group: ,55 vs. ./ = 55 (ref) 0.50 [0.29, 0.86] 0.01 0.47 [0.26, 0.85] 0.01 1.48 [0.67, 3.28] 0.33 Not in final model N/A
Place of Residence: urban (ref) vs. rural 4.86 [2.75, 8.58] ,0.001 2.69 [1.31, 5.53] 0.01 12.07 [4.44, 32.81] ,0.001 5.13 [1.53, 17.13] 0.008
Education level: below high school
vs. high school or above (ref)
1.57 [0.93, 2.65] 0.09 Not in final model N/A 2.37 [0.88, 6.43] 0.09 Not in final model N/A
Employment: Yes (ref) vs. No 0.93 [0.35, 2.49] 0.89 Not in final model N/A 1.21 [0.26, 5.58] 0.81 Not in final model N/A
Social/private insurance: Yes (ref) vs. No 5.62 [2.75, 11.50] ,0.001 2.05 [0.82, 5.11] 0.13 7.57 [3.36, 17.02] ,0.001 1.36 [0.49, 3.81] 0.56
Highest income group (ref) Reference Reference Reference Reference
Middle income group 4.31 [2.05, 9.07] ,0.001 2.40 [1.03, 5.56] 0.04 16.08 [4.20, 61.53] ,0.001 7.23 [1.65, 31.71] 0.009
Lowest income group 2.81 [1.58, 5.01] ,0.001 1.62 [0.84, 3.11] 0.13 14.11 [3.97, 50.10] ,0.001 6.67 [1.69, 26.35] 0.007
Presentation: ACS (ref) vs. stroke 1.00 [0.62, 1.61] 0.99 Not in final model N/A 1.06 [0.49, 2.28] 0.89 Not in final model N/A
The multivariate models were constructed using variables that were significant (p,0.1) in the univariate models and included a dichotomy variable to reflect the type of
event, that is 1 for acute coronary syndrome and 0 for stroke.
doi:10.1371/journal.pone.0020821.t003
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Table 4. Univariate and multivariate logistic regression models for catastrophic health spending and distress financing by for India
and Tanzania (see Table 3 for Argentina and China).
Catastrophic Health Spending Distress Financing
Univariate
analysis
p-
value
Multivariate
analysis
p-
value
Univariate
analysis
p-
value
Multivariate
analysis
p-
value
India (n=500) OR [95% CI] OR [95% CI] OR [95% CI] OR [95% CI]
Age Group: ,55 vs. ./ = 55 (ref) 1.68 [1.13, 2.51] 0.01 1.66 [1.06, 2.61] 0.03 0.69 [0.49, 0.99] 0.04 0.57 [0.38, 0.87] 0.009
Place of Residence: urban (ref) vs. rural 1.93 [1.29, 2.90] ,0.001 1.28 [0.82, 2.00] 0.28 2.11 [1.47, 3.03] ,0.001 1.93 [1.27, 2.93] 0.002
Education level: below high school
vs. high school or above (ref)
1.83 [1.09, 3.09] 0.02 1.00 [0.54, 1.86] 1.00 2.10 [1.36, 3.25] ,0.01 2.27 [1.34, 3.86] 0.002
Employment: Yes (ref) vs. No 1.83 [1.10, 3.05] 0.02 0.90 [0.50, 1.60] 0.71 1.45 [0.95, 2.20] 0.08 Not in final model N/A
Social/private insurance: Yes (ref) vs. No 4.42 [2.63, 7.41] ,0.001 3.93 [2.23, 6.90] ,0.001 11.19 [5.24, 23.92] ,0.001 11.37 [5.18, 24.95] ,0.001
Highest income group (ref) Reference Reference Reference Reference
Middle income group 4.32 [2.22, 8.41] ,0.001 3.66 [1.83, 7.30] ,0.01 1.10 [0.70, 1.73] 0.67 0.96 [0.58, 1.61] 0.885
Lowest income group 6.67 [2.61, 17.04] ,0.001 6.59 [2.23, 19.45] ,0.001 1.81 [1.05, 3.13] 0.03 1.30 [0.68, 2.49] 0.429
Presentation: ACS (ref) vs. stroke 0.96 [0.63, 1.46] 0.84 0.60 [0.37, 0.97] 0.04 0.50 [0.34, 0.74] ,0.001 0.32 [0.21, 0.51] ,0.001
Tanzania (n =498)
Age Group: ,55 vs. ./ = 55 (ref) 1.41 [0.84, 2.36] 0.20 Not in final model N/A 0.90 [0.47, 1.73] 0.76 Not in final model N/A
Place of Residence: urban (ref) vs. rural 1.99 [1.13, 3.49] 0.01 2.00 [1.07, 3.73] 0.03 0.83 [0.43, 1.63] 0.60 Not in final model N/A
Education level: below high school
vs. high school or above (ref)
2.35 [1.37, 4.03] ,0.001 1.47 [0.79, 2.74] 0.22 1.24 [0.53, 2.87] 0.62 Not in final model N/A
Employment: Yes (ref) vs. No 1.05 [0.94, 1.17] 0.37 Not in final model N/A 1.00 [0.87, 1.15] 0.99 Not in final model N/A
Social/private insurance: Yes (ref) vs. No 4.71 [2.59, 8.59] ,0.001 3.68 [1.86, 7.26] ,0.001 6.91 [0.93, 51.10] 0.06 Not in final model N/A
Highest income group (ref) Reference Reference Reference Reference
Middle income group 2.65 [1.41, 5.00] ,0.001 2.14 [0.98, 4.64] 0.05 1.38 [0.43, 4.47] 0.59 Not in final model N/A
Lowest income group 4.37 [2.13, 8.98] ,0.001 2.34 [0.68, 8.05] 0.17 3.25 [1.08, 9.75] 0.03 3.25 [1.08, 9.75] 0.03
Presentation: ACS (ref) vs. stroke 1.72 [0.35, 85.69] 0.47 Not in final model N/A 0.91 [0.11, 7.50] 0.93 Not in final model N/A
The multivariate models were constructed using variables that were significant (p,0.1) in the univariate models.
doi:10.1371/journal.pone.0020821.t004
Table 5. Functional health effects, productivity effects, and household effects of CVD-related hospitalization among respondents
from Argentina, China, India, and Tanzania.
Argentina
N=367
China
N=290
India
N=500
Tanzania
N=498
Low
(n=76)
Middle
(n=202)
High
(n=89)
Low
(n=44)
Middle
(n =78)
High
(n =168)
Low
(n=66)
Middle
(n =99)
High
(n =335)
Low
(n=200)
Middle
(n=198)
High
(n=100)
FUNCTIONAL HEALTH EFFECTS
Reporting decrease in self-rated health, % 47.4 45.0 52.8 61.4 60.3 57.7 60.6 64.6 58.7 94.0 95.9 98.0
Decreased moderate activity ability, % 86.8 86.1 86.5 47.7 61.5 54.2 42.4 49.5 44.0 79.4 88.2 86.5*
Decreased vigorous activity ability, % 90.8 86.6 88.8 81.8 83.3 73.2 66.7 63.6 66.2 92.3 95.3 97.2
Experiencing emotional problems, % 72.4 59.4 57.3 40.9 50.0 50.4 9.1 20.2 32.5 61.0 73.2 80.0
Unable to take medications due to cost, % 13.3 7.3 10.6 43.8 29.6 7.1* 6.1 10.1 8.1 94.4 99.5 99.0*
PRODUCTIVITY EFFECTS
Decreased work time, % 77.6 75.7 70.4 90.9 87.2 70.2* 90.9 87.9 81.7 98.9 98.5 100.0
Limited work activities, % 86.8 78.2 74.7 86.4 92.3 85.7 90.9 90.9 85.9 98.9 98.5 100.0
Feeling limited, % 86.7 65.8 57.3 90.9 92.3 88.7 89.4 90.8 85.7 98.5 98.5 99.0
HOUSEHOLD EFFECTS
Decreased work time (or stopping work)
by family members, %
11.8 9.9 6.7 20.5 17.9 10.1 4.6 4.3 2.4 18.9 21.4 24.7
Increased work time (or starting work)
by family members, %
17.1 20.8 22.5 34.1 24.4 7.1* 13.8 8.2 5.7 16.3 14.9 11.3
Differences across income strata were considered statistically significant if p,0.05 (*).
doi:10.1371/journal.pone.0020821.t005
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their work time (14%) was similar to the proportion that decreased
their work time (15%), but the increase in work time by family
members was most common in the low-income stratum (Table 5).
India. Almost two-thirds of respondents reported a decrease
in their self-rated health (60%). Less than half of participants
reported a worsening of their ability to perform moderate activities
(45%), while two-thirds reported a worsening of their ability to
perform vigorous activities, both of which trended lower than
the other comparator countries. The proportion of individuals
reporting emotional problems following their CVD-related hos-
pitalization was also lower than the comparator countries (27%)
but highest in the high-income strata (33%). Approximately one in
ten respondents across all income strata did not take their
medications due to cost (Table 5).
More than three-fourths of respondents decreased their work
time, limited their work activities, and felt limited overall. A
slightly greater proportion of family members increased their work
time rather than decrease their work time following the re-
spondent’s CVD-related hospitalization, and this trend was most
marked in the low-income stratum (Table 5).
United Republic of Tanzania. Nearly all respondents across
all income strata reported a decrease in their self-rated health
(96%) with a corresponding worsening in their ability to parti-
cipate in moderate (84%) and vigorous (96%) activities. The
proportion of individuals reporting emotional problems following
their CVD-related hospitalization was high overall (70%) and
highest in the high-income strata. Approximately one-third of the
respondents did not take their medications as prescribed, which
was largely due to the highs costs (76%) (Table 5).
Nearly all respondents decreased their work time, limited their
work activities, and felt limited overall (99%) following their CVD-
related hospitalization. A greater proportion of family members
decreased their work time rather than increased their work time to
care for the patient (Table 5).
Discussion
Health Care Spending
We evaluated the individual- and household-level impact of
CVD-related hospitalization across four LMIC and found that 15-
month out-of-pocket CVD expenditures varied considerably across
countries and across income groups within countries (INT$374
[Tanzania, low-income] to INT$2,917 [India, high-income]). By
comparison, in-hospital out-of-pocket expenditures for CVD in the
United States were estimated to be INT$1,229 in 2006 [7].
In two of the four countries studied, CVD costs are regressive:
poorer respondents pay a higher proportion of income on health
care following a CVD hospitalization, as previously demonstrated
for other conditions in other countries [8,9]. The examples of
Argentina and Tanzania in our survey shows that regressive CVD
costs are not universal in LMIC [10] and suggests there is a wide
range of country-specific, economic and/or health system deve-
lopment within the LMIC category.
Financing Mechanisms and Impoverishing Effects of CVD
Catastrophic health spending was common in China, India, and
Tanzania and most strongly impacted the poorest CVD patients
and their families. Our results are markedly higher than mean
levels of CHS previously reported among community dwellers in
89 countries (2.3%) [4,11]. Global estimates for CHS range from
almost zero percent in the United Kingdom, Czech Republic, and
Slovakia to .10% percent in Vietnam and Brazil [11]. However,
since our study focused on recently hospitalized patients, our
figures would be expected to be higher, though perhaps not to this
degree. The high proportion of CHS may be underestimated
because of individuals who avoid medical treatment due to high,
perceived costs, yet might have financial insecurity if they did. On
the other hand, distress financing—risky financial activities such as
borrowing loans and selling assets—was present in .40% of
participants only in India. Participants from Argentina, China,
and Tanzania most commonly borrowed money from family,
friends, and employers to cover their health care costs, whereas
more than half of participants who experienced distress financing
in India borrowed from banks/moneylenders or sold assets.
A 2009 survey evaluating the microeconomic impact of stroke
across 62 hospitals in China found that 71% of post-stroke patients
reported CHS. While the authors used a different definition of
CHS ($30% of annual income), the findings are similar overall to
our results (the range of CHS in our sample from China across
income groups was 37–71%) [13]. However, in our sample, CHS
was not associated with hospitalization due to stroke compared
with acute coronary syndromes, which may be due to higher costs
of acute coronary syndromes or a lack of power to detect such a
difference. This comparison across Argentina, China, India, and
Tanzania provides a wider scope of the individual- and household-
level economic impact of CVD-related hospitalizations.
Along with high CVD-related costs, many participants reported
decreased income, poorer perceived health (including emotional
problems), lower functional and productivity capacity, and
variable household effects, all of which likely exacerbated their
financial instability. These findings, coupled with the relatively low
proportion of any form of insurance, likely contributed to the high
proportion of CHS. Some argue that CHS overestimates the
impoverishing effects of health care costs since families are able to
‘‘smooth consumption’’ by drawing upon savings, assets, credit
and loans from friends and relatives [12]. We tried to account for
such activities through questions about distress financing, which
may offset CHS but contributes to chronic impoverishment [12].
Lack of private/social health insurance was significantly asso-
ciated with an increased risk of CHS in 3 of 4 countries studied
and a trend toward association in China. Insurance alone,
however, does not protect fully against CHS, as evident in our
study with the high proportion of CHS in China despite a rela-
tively higher proportion of insurance coverage. This discrepancy
may be due, in part, to the proportion of reimbursement by the
insurer, which was lowest for both hospital and outpatient charges
in the low-income group and rural respondents in China (data not
shown). On the other hand, low-income respondents were more
likely to experience distress financing in 3 of 4 countries, sug-
gesting that poorer participants may be less likely to have financial
reserves to bear the costs of a CVD-related hospitalization. The
availability of health services requiring payment, national in-
equality in health spending, and the capacity of individuals and
households to pay (non-subsistence spending) are other key deter-
minants associated with CHS [11].
Solutions to Avoid Catastrophic Health Spending and
Distress Financing
The primary means to avoid distress financing typically includes
prepayment either through tax financing, social health insurance
programs, or private health insurance programs, the latter two
which have been shown to reduce CHS incidence in Mexico [13].
On the other hand, social health insurance programs have been
shown to increase per capita health spending by 3–4% without
improved outcomes or even at the cost of 5–6% potential life years
lost in one report [14,15]. Other studies have demonstrated an
increase in CHS with a decrease in the depth of insurance,
including evaluations of China’s urban and rural insurance
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schemes, which promote more complex, expensive care that is not
wholly covered [16,17]. Another mechanism to decrease CHS and
distress financing is to reduce the supply side of health care
through restrictions in spending opportunities (treatment proto-
cols, essential drug lists, restriction of unnecessary interventions,
e.g.), which has been shown to be more successful at reducing
CHS in China than expansion of insurance coverage alone [18].
Limitations
Our study has inherent limitations. First, our survey sample was
hospital-based, and did not sample patients who avoided seeking
care for a CVD event nor those who did not survive a CVD event
during the follow-up period: this may bias the results by describing
only the most severe events, or by missing patients who avoided
seeking medical care or those who did not survive a CVD event.
Second, participants were asked to report sensitive income and
expenditure information up to 15 months after hospitalization,
which may be susceptible to reporting bias. Third, our survey
captured participants from selected hospitals from each country,
which should not be considered generalizable to other hospitals.
We did, however, attempt to capture a large number of respon-
dents to effectively evaluate the economic effects of CVD-related
hospitalizations in these selected LMIC, though country sample
sizes per country were not proportionate to overall country
population sizes. Fourth, our sample size may have been too small
to detect differences in the distribution and determinants of CHS
and DF. Fifth, many patients could not afford costly treatments
like medications, percutaneous coronary intervention or coronary
artery bypass graft surgery nor diagnostics and follow-up care and
subsequently did not undergo them, which may underestimate
expenditures in an evidence-based treatment setting. Sixth, we did
not exhaust all the potentially relevant microeconomic conse-
quences of CVD hospitalization, such as savings or labor supply.
Conclusions
Patients in Argentina, China, India, and Tanzania bear a sig-
nificant burden of out-of-pocket payments, as defined by CHS and
DF, following CVD hospitalization, though substantial variations
exist across and within countries. Lack of insurance appears to be a
major, remediable source of the financial burden of CVD in these
countries. As CVD prevalence increases in LMIC, the household
economic impact of CVD may worsen without the development of
alternative health spending models that enhance patients’ capacity
to pay or without more active policies to prevent or at least post-
pone the onset of CVD in LMIC.
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